Synthesis, Characterization, and Interaction with Biomolecules of Platinum(II) Complexes with Shikimic Acid-Based Ligands
暂无分享,去创建一个
Hong Liang | Zhenfeng Chen | Min-min Zhang | Yan Peng | Xia Chen | Kun Hu | Yancheng Liu | H. Liang | Yan-cheng Liu
[1] T. Mueller,et al. Lipophilic Pt(II) complexes with selective efficacy against cisplatin-resistant testicular cancer cells. , 2011, Journal of inorganic biochemistry.
[2] M. Jakupec,et al. Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin , 2011, European journal of medicinal chemistry.
[3] I. Santos,et al. Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies. , 2011, Dalton transactions.
[4] U. Jaehde,et al. Enhancing lipophilicity as a strategy to overcome resistance against platinum complexes? , 2011, Journal of inorganic biochemistry.
[5] V. Rodríguez,et al. Novel C,N-chelate platinum(II) antitumor complexes bearing a lipophilic ethisterone pendant. , 2011, Journal of inorganic biochemistry.
[6] J. Platts,et al. Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes , 2011, JBIC Journal of Biological Inorganic Chemistry.
[7] Hong Liang,et al. High cytotoxicity of dihalo-substituted 8-quinolinolato-lanthanides. , 2011, Dalton transactions.
[8] D. N'Da,et al. Water-Soluble Macromolecular Platinum Conjugates Derived from 1,2-Dihydroxyl-Functionalized Carrier Polymers , 2010 .
[9] A. Chaudhuri,et al. Cationic amphiphile with shikimic acid headgroup shows more systemic promise than its mannosyl analogue as DNA vaccine carrier in dendritic cell based genetic immunization. , 2010, Journal of Medicinal Chemistry.
[10] D. Migoni,et al. Water‐soluble Organometallic Analogues of Oxaliplatin with Cytotoxic and Anticlonogenic Activity , 2010, ChemMedChem.
[11] A. Spek,et al. Mono- and dinuclear platinum(II) compounds with 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine. Structure, cytotoxic activity and reaction with 5'-GMP. , 2009, Dalton transactions.
[12] M. Schürmann,et al. On the many roles of NH3 ligands in mono- and multinuclear complexes of platinum. , 2009, Dalton transactions.
[13] D. Gibson. The mechanism of action of platinum anticancer agents--what do we really know about it? , 2009, Dalton transactions.
[14] D. Osella,et al. The drug targeting and delivery approach applied to pt-antitumour complexes. A coordination point of view. , 2009, Current medicinal chemistry.
[15] U. Häfeli,et al. Long-chain rhenium and technetium glucosamine conjugates. , 2009, Dalton transactions.
[16] Katherine S. Lovejoy,et al. Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting. , 2009, Dalton transactions.
[17] F. Zunino,et al. Strategies to improve the efficacy of platinum compounds. , 2009, Current medicinal chemistry.
[18] Yi-zhi Li,et al. Binuclear monofunctional platinum(II) complexes formed by hexaazamacrocyclic bisdien ligands: Crystal structure, DNA binding and cytotoxicity studies , 2009 .
[19] R. Schibli,et al. Novel glycated [99mTc(CO)3]-labeled bombesin analogues for improved targeting of gastrin-releasing peptide receptor-positive tumors. , 2008, Bioconjugate chemistry.
[20] B. Keppler,et al. Carbohydrate-metal complexes and their potential as anticancer agents. , 2008, Current medicinal chemistry.
[21] Katherine S. Lovejoy,et al. cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects , 2008, Proceedings of the National Academy of Sciences.
[22] K. Geckeler,et al. Supramolecular nanoencapsulation as a tool: solubilization of the anticancer drug trans-dichloro(dipyridine)platinum(II) by complexation with beta-cyclodextrin. , 2008, Molecular pharmaceutics.
[23] F. Schmidtchen,et al. A novel synthesis of chiral guanidinium receptors and their use in unfolding the energetics of enantiorecognition of chiral carboxylates. , 2008, The Journal of organic chemistry.
[24] L. Kèlland,et al. The resurgence of platinum-based cancer chemotherapy , 2007, Nature Reviews Cancer.
[25] M. Hall,et al. Basis for design and development of platinum(IV) anticancer complexes. , 2007, Journal of medicinal chemistry.
[26] Stephen J Lippard,et al. Direct cellular responses to platinum-induced DNA damage. , 2007, Chemical reviews.
[27] A. Beck‐Sickinger,et al. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors. , 2007, The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
[28] J. Schellens,et al. Phase I and pharmacokinetic trial of AP5346, a DACH–platinum–polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients , 2007, Cancer Chemotherapy and Pharmacology.
[29] M. Dolan,et al. Molecular mechanisms of resistance and toxicity associated with platinating agents. , 2007, Cancer treatment reviews.
[30] Veronique Maes,et al. Novel 99mTc-labeled neurotensin analogues with optimized biodistribution properties. , 2006, Journal of medicinal chemistry.
[31] Dik‐Lung Ma,et al. Water soluble luminescent platinum terpyridine complexes with glycosylated acetylide and arylacetylide ligands: photoluminescent properties and cytotoxicities. , 2005, Chemical communications.
[32] Mark T. Johnson,et al. A Water-Soluble Polyamide Containing cis-dicarboxylato-chelated Platinum(II) , 2005 .
[33] L. Collette,et al. Phase III Trial of Satraplatin, an Oral Platinum plus Prednisone vs. Prednisone alone in Patients with Hormone-Refractory Prostate Cancer , 2005, Oncology.
[34] R. Knuechel,et al. Distribution and subcellular localization of a water-soluble hematoporphyrin-platinum(II) complex in human bladder cancer cells. , 2004, Cancer letters.
[35] F. Avilés,et al. Water-soluble platinum(II) complexes of diamine chelating ligands bearing amino-acid type substituents: the effect of the linked amino acid and the diamine chelate ring size on antitumor activity, and interactions with 5'-GMP and DNA. , 2004, Journal of inorganic biochemistry.
[36] E. Framery,et al. Palladium-catalyzed asymmetric allylic alkylation using chiral glucosamine-based monophosphines , 2003 .
[37] P. Wang,et al. Expeditious syntheses of two carbohydrate-linked cisplatin analogs. , 2002, Carbohydrate research.
[38] Y. Sohn,et al. Synthesis and selective tumor targeting properties of water soluble porphyrin-Pt(II) conjugates. , 2002, Journal of inorganic biochemistry.
[39] W. Zimmermann,et al. (Aminoethanol)dichloroplatinum(II) complexes: influence of the hydroxyethyl moiety on 5'-GMP and DNA binding, intramolecular stability, the partition coefficient and anticancer activity. , 2002, Journal of inorganic biochemistry.
[40] T. Okamoto,et al. Unprecedented sugar-dependent in vivo antitumor activity of carbohydrate-pendant cis-diamminedichloroplatinum(II) complexes. , 2001, Bioorganic & medicinal chemistry letters.
[41] W. Denny,et al. cis-Dichloroplatinum(II) complexes tethered to 9-aminoacridine-4-carboxamides: synthesis and action in resistant cell lines in vitro. , 2001, Journal of inorganic biochemistry.
[42] E. T. Cesar,et al. Synthesis of Platinum Complexes from Sugar Derivatives , 2000 .
[43] J. Reedijk. Why does Cisplatin reach Guanine-n7 with competing s-donor ligands available in the cell? , 1999, Chemical reviews.
[44] C. Giandomenico,et al. Current status of platinum-based antitumor drugs. , 1999, Chemical reviews.
[45] S. Lippard,et al. Structure, Recognition, and Processing of Cisplatin-DNA Adducts. , 1999, Chemical reviews.
[46] P. Wang,et al. A Carbohydrate-Linked Cisplatin Analogue Having Antitumor Activity. , 1999, Angewandte Chemie.
[47] D. Lebwohl,et al. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. , 1998, European journal of cancer.
[48] A. Spatola,et al. Mechanism of Palladium-Catalyzed Transfer Hydrogenolysis of Aryl Chlorides by Formate Salts , 1995 .
[49] J. Kozelka,et al. Effect of platinum N7-binding to deoxyguanosine and deoxyadenosine on the H8 and H2 chemical shifts. A quantitative analysis , 1994 .
[50] Y. Kitano,et al. Synthesis, structure and antitumor activity of a new water-soluble platinum complex, (1R,2R-cyclohexanediamine-N,N')[2-hydroxy-4-oxo-2-pentenoato(2-)-O2] platinum(II). , 1993, Chemical & pharmaceutical bulletin.
[51] W. Denny,et al. DNA-directed alkylating agents. 5. Acridinecarboxamide derivatives of (1,2-diaminoethane)dichloroplatinum(II). , 1992, Journal of medicinal chemistry.
[52] Y. Kitano,et al. Synthesis, Structure and Antitumor of a Water-Soluble Platinum Complex, (1R, 3R, 4R, 5R)-(-)-Quinato(1R, 2R-cyclohexanediamine)platinum(II) , 1992 .
[53] N. Farrell,et al. Shikimic acid complexes of platinum. Preparation, reactivity, and antitumor activity of (R,R-1,2-diaminocyclohexane) bis(shikimato) platinum(II). Evidence for a novel rearrangement involving platinum-carbon bond formation. , 1991, Journal of inorganic biochemistry.
[54] F. Zunino,et al. New Cisplatin Analogues—On the Way to Better Antitumor Agents , 1987 .
[55] L. Marzilli,et al. Interaction of platinum antitumor agents with guanine nucleosides and nucleotides. Platinum-195 and proton NMR spectroscopic characterization of compound III , 1985 .
[56] P. Lohman,et al. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. , 1985, Biochemistry.
[57] A. Marcelis,et al. Reaction products of cis-diammineplatinum(II) compounds with 5'-guanosine monophosphate characterized by high-frequency proton NMR , 1984 .
[58] H. C. Clark,et al. Preparation and characterization of platinum(II) complexes Pt(P-C)LX, where (P-C) is metalated tri-tert-butylphosphine , 1980 .
[59] J. Trosko,et al. Platinum Compounds: a New Class of Potent Antitumour Agents , 1969, Nature.
[60] Valeria Panebianco,et al. Supplementary Figure 2 , 2012 .
[61] M. Jakupec,et al. Tuning of lipophilicity and cytotoxic potency by structural variation of anticancer platinum(IV) complexes. , 2011, Journal of inorganic biochemistry.
[62] Igor V Tetko,et al. Calculation of lipophilicity for Pt(II) complexes: experimental comparison of several methods , 2008, Journal of inorganic biochemistry.
[63] P. Pochet. A Quantitative Analysis , 2006 .
[64] Sun Li-min. Application of ammonium formate in catalytic transfer hydrogenation , 2005 .
[65] R. Weiss,et al. New Cisplatin Analogues in Development A Review , 2022 .